TXAC - Therapeutics Acquisition Corp. trade ideas

Fundamentals:
Basic Info:
  • Market Cap:
  • Exchange:
  • Shares Float:
  • Shares Outstanding:
  • Number of Employees:
  • Book value per share:
Advanced Info:
  • ROE ttm:
  • ROA ttm:
  • Beta:
  • EPS:
  • Debt Ratio ttm:
  • Debt / Equity Ratio ttm:
  • Payout Ratio ttm:
Cash Ratios:
  • Cash Ratio ttm:
  • Current Ratio ttm:
  • Quick Ratio ttm:
Key Ratios:
  • P/E trailing 12 month:
  • P/E forward:
  • P/E trailing 12m high:
  • P/E trailing 12m low:
  • P/S trailing 12 month:
  • EV/S trailing 12 month:
  • P/B trailing 12 month:
  • PEG ratio:
  • Free Cash Flow Yield (FCF/EV):
Shorts:
  • Shares Short:
  • Shares Short Prev Month:
  • Days to Cover:
  • Short Percent Float:
  • Short Percent Outstanding:
Ownership:
  • Percent Insiders:
  • Percent Institutions:
Margins:
  • Gross Profit Margin ttm:
  • EBITDA Margin ttm:
  • Operating Margin ttm:
  • Net Income Margin ttm:
Target Prices:
  • Target Price High:
  • Target Price Low:
  • Target Price Mean:
  • Number of Analysts:
Key Prices:
  • 52 Week High:
  • 52 Week Low:
  • 50 Day Moving Average:
  • 200 Day Moving Average:
Dividends:
  • Trailing Dividend yield:
  • Forward Dividend yield:
  • Payout Ratio:
  • Ex-Dividend date:
Current Quarter Estimates:
  • Current Quarter EPS estimate:
  • Current Quarter revenue estimate:
Next Quarter Estimates:
  • Login to see the next quarter estimates
  • Login
Latest News:
Click to expand the area.
Income Statements:
TXAC - Therapeutics Acquisition Corp. Income Statement
Unit: (million USD)
Qtr Revenue
Rev Growth yoy
Cost of Revenue
Gross Profit
Gross Profit Mgn
Research and Development
Selling, General & Administrative Expense
Operating Income
Operating Mgn
Net Income
Net Income Mgn
Crafted by @tradeideashq with 💡
Cashflow Statements:
Not available at this time...
Balance Sheets:
TXAC - Therapeutics Acquisition Corp. Balance Sheet
Unit: (million)
Total Assets
Intangible Assets
Goodwill
Current Assets
Current Cash
Account Receivables
Inventory
Total Liabilities
Account Payables
Short Term Debt
Long Term Debt
Current Ratio
Debt Ratio
Debt/Equity Ratio
Crafted by @tradeideashq with 💡
Latest Posts:
Not available at this time..
Therapeutics Acquisition Corp.
Therapeutics Acquisition Corp.

Therapeutics Acquisition Corp. is a blank check company with a purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Peter Kolchinsky and Matthew Hammond on April 15, 2020 and is headquartered in Boston, MA.
CEO: Peter Kolchinsky
Sector: Finance
Industry: Financial Conglomerates
Full Time Employees:
Keywords: therapeutics acquisition corp.
Stock Price:
TXAC - Therapeutics Acquisition Corp. Stock Price
Basic Info:
  • Market Cap:
  • Exchange:
  • Shares Float:
  • Shares Outstanding:
  • Number of Employees:
  • Book value per share:
Advanced Info:
  • ROE ttm:
  • ROA ttm:
  • Beta:
  • EPS:
  • Debt Ratio ttm:
  • Debt / Equity Ratio ttm:
  • Payout Ratio ttm:
Cash Ratios:
  • Cash Ratio ttm:
  • Current Ratio ttm:
  • Quick Ratio ttm:
Key Ratios:
  • P/E trailing 12 month:
  • P/E forward:
  • P/E trailing 12m high:
  • P/E trailing 12m low:
  • P/S trailing 12 month:
  • EV/S trailing 12 month:
  • P/B trailing 12 month:
  • PEG ratio:
  • Free Cash Flow Yield (FCF/EV):
Shorts:
  • Shares Short:
  • Shares Short Prev Month:
  • Days to Cover:
  • Short Percent Float:
  • Short Percent Outstanding:
Ownership:
  • Percent Insiders:
  • Percent Institutions:
Margins:
  • Gross Profit Margin ttm:
  • EBITDA Margin ttm:
  • Operating Margin ttm:
  • Net Income Margin ttm:
Target Prices:
  • Target Price High:
  • Target Price Low:
  • Target Price Mean:
  • Number of Analysts:
Key Prices:
  • 52 Week High:
  • 52 Week Low:
  • 50 Day Moving Average:
  • 200 Day Moving Average:
Dividends:
  • Trailing Dividend yield:
  • Forward Dividend yield:
  • Payout Ratio:
  • Ex-Dividend date:
Current Quarter Estimates:
  • Current Quarter EPS estimate:
  • Current Quarter revenue estimate:
Next Quarter Estimates:
  • Login to see the next quarter estimates
  • Login
Click to expand the area.
Analyst Consensus:
TXAC - Therapeutics Acquisition Corp. Analyst Opinions

Crafted by @tradeideashq with ❤️
Analyst Trends:
TXAC - Therapeutics Acquisition Corp. Analyst Trends
Crafted by @tradeideashq with 💡
Website Ranking Analysis:
Google Trends Analysis:
TXAC - Therapeutics Acquisition Corp. Google Trends Analysis
Crafted by @tradeideashq with ❤️
Employees Analysis:
TXAC - Therapeutics Acquisition Corp. Employees Analysis
Generated by @tradeideashq with 💡
Institution & Insiders Analysis:
TXAC - Therapeutics Acquisition Corp. Ownership Analysis
Crafted by @tradeideashq with 💡
Debt & Cash Analysis:
TXAC - Therapeutics Acquisition Corp. Cash Analysis (unit: )
Crafted by @tradeideashq with 💡
Short Analysis:
TXAC - Therapeutics Acquisition Corp.  Short Analysis
Crafted by @tradeideashq with 💡
Margins and Revenue:
TXAC - Therapeutics Acquisition Corp. Revenue and Margins Analysis
Generated by @earningsfly with ❤️
Income Statement Analysis:
TXAC - Therapeutics Acquisition Corp. Income Statement
Unit: (million USD)
Qtr Revenue
Rev Growth yoy
Cost of Revenue
Gross Profit
Gross Profit Mgn
Research and Development
Selling, General & Administrative Expense
Operating Income
Operating Mgn
Net Income
Net Income Mgn
Crafted by @tradeideashq with 💡
Earnings Estimate Analysis:
Not available at this time...
Cashflow Analysis:
Not available at this time...